Skip to main content

Provectus Biopharmaceuticals, Inc.

PVCT
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0000315545

No open-market purchases or sales by Provectus Biopharmaceuticals, Inc. insiders were filed in the last 90 days; 4 institutions reported holding it in 13F filings for Q2 2026, worth $8.97K in total; no superinvestor holds it.

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, −2 vs. previous quarter
4
13F valueReported value at the end of Q2 2026
$8.97K
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding PVCT, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding PVCT at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by Provectus Biopharmaceuticals, Inc. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Feb 11, 2026 (view filing)Feb 92 daysPershing EdwardCEOPPurchase+349.4K$0.286+$99.9K–2.61M afterDerivative
Nov 25, 2024 (view filing)Nov 223 daysPershing EdwardCEOPPurchase+803.6K$0.286+$229.8K–1.69M afterDerivative
Oct 19, 2023 (view filing)5:16 PM ETOct 316 daysLatePershing EdwardDirectorPPurchase+193.1K$0.2862+$55.3K–690.8K afterDerivative
Sep 20, 2022 (view filing)5:26 PM ETSep 164 daysRodrigues DominicDirectorPPurchase+11.4M$0.2862+$3.27M–11.4M afterDerivative

Top 10 13F holders, Q2 2026

The largest institutional positions in Provectus Biopharmaceuticals, Inc. at the end of Q2 2026; share changes are against Q1 2026.

See all 4 holders
Institutions holding PVCT in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Home Federal Bank of Tennessee100,000$6.90K0.00%00.0%Unchanged
Atlas Wealth LLC19,620$1.36K0.00%00.0%Unchanged
Financial Symmetry Inc10,191$7070.00%00.0%Unchanged
Huntington National Bank1$00.00%00.0%Unchanged